← Leaderboards
Jodi McGill
Iowa State University
$1,268,187
Attributed
$2,306,873
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $575.6K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,306,873 · 2
By mechanism
R01$2,077,373 · 1
R21$229,500 · 1
Top collaborators
- Randy E Sacco4 shared
Most similar at Iowa State University
Same institution · by research overlap
- Balaji Narasimhan$10,147,669
- Marian L Kohut$5,498,591
- Randy E Sacco$1,038,687
- Maria P Torres-Gonzalez$53,588
- Michael J Wannemuehler$142,961
Others in their field
Other Emerging Leaders on “Infant”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,941,048
- Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr$15,645,835
- Sara Bonamo Demauro · Children'S Hosp Of Philadelphia$11,606,693
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
InfantMorbidity - Disease RateImmuneImmunocompromised HostLower Respiratory Tract InfectionMicroscopicChildHigh RiskImmune SystemImmunityInfectionLifeAnimalsMature AnimalAcuteAntiviral ImmunityElderlyCattleAdultImmune ResponseAllergic Airway DiseaseDesignExperimental StudyMouse Model
Grant awards (5)
Development of a mucosal, polyanhydride-based nanoparticle vaccine for use against RSV infection in the neonate$528,103
R01 · FY2022 · HD · contact PI
Development of a mucosal, polyanhydride-based nanoparticle vaccine for use against RSV infection in the neonate$575,637
R01 · FY2021 · HD · contact PI
Development of a mucosal, polyanhydride-based nanoparticle vaccine for use against RSV infection in the neonate$437,042
R01 · FY2020 · HD · contact PI
Development of a mucosal, polyanhydride-based nanoparticle vaccine for use against RSV infection in the neonate$536,591
R01 · FY2019 · HD · contact PI
Determining the role of Interleukin-17 in the Immune Response to Respiratory Syncytial Virus Infection$229,500
R21 · FY2018 · AI · contact PI